1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11428
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTeh, B-
dc.contributor.authorGrayson, M Lindsay-
dc.contributor.authorJohnson, Paul D R-
dc.contributor.authorCharles, Patrick G P-
dc.date.accessioned2015-05-16T01:02:12Z
dc.date.available2015-05-16T01:02:12Z
dc.date.issued2012-01-27-
dc.identifier.citationClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012; 18(4): E71-3en_US
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/11428en
dc.description.abstractWe assessed the comparative efficacy of empirical therapy with beta-lactam plus macrolide vs. beta-lactam plus doxycycline for the treatment of community-acquired pneumonia (CAP) among patients in the Australian Community-Acquired Pneumonia Study. Both regimens demonstrated similar outcomes against CAP due to either 'atypical' (Chlamydophila, Legionella or Mycoplasma spp.) or typical bacterial pathogens.en_US
dc.language.isoenen
dc.subject.otherAdulten
dc.subject.otherAgeden
dc.subject.otherAged, 80 and overen
dc.subject.otherAnti-Bacterial Agents.therapeutic useen
dc.subject.otherAustralia.epidemiologyen
dc.subject.otherChlamydophila.pathogenicityen
dc.subject.otherCommunity-Acquired Infections.drug therapy.epidemiology.microbiologyen
dc.subject.otherDoxycycline.therapeutic useen
dc.subject.otherDrug Therapy, Combinationen
dc.subject.otherFemaleen
dc.subject.otherGram-Negative Bacterial Infections.drug therapy.epidemiology.microbiologyen
dc.subject.otherHumansen
dc.subject.otherLegionella.pathogenicityen
dc.subject.otherMacrolides.therapeutic useen
dc.subject.otherMaleen
dc.subject.otherMiddle Ageden
dc.subject.otherMycoplasma.pathogenicityen
dc.subject.otherMycoplasma Infections.drug therapy.epidemiology.microbiologyen
dc.subject.otherPneumonia, Bacterial.drug therapy.epidemiology.microbiologyen
dc.subject.otherProspective Studiesen
dc.subject.otherSeverity of Illness Indexen
dc.subject.otherTreatment Outcomeen
dc.subject.otherYoung Adulten
dc.subject.otherbeta-Lactams.therapeutic useen
dc.titleDoxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseasesen_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.doi10.1111/j.1469-0691.2011.03759.xen_US
dc.description.pagesE71-3en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/22284533en
dc.type.contentTexten_US
dc.type.austinJournal Articleen
local.name.researcherCharles, Patrick G P
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptGeneral Medicine-
crisitem.author.deptInfectious Diseases-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

66
checked on Dec 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.